Table of content for "Tixagev and cilgav, 300mg" (HCPCS Q0220)
General information on the “Q0220” code
HCPCS Code: Q0220
Long Description: Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg
Short Description: Tixagev and cilgav, 300mg
Original information is taken from Q0220 page
Pricing indicators
Pricing Indicator Code 1: 54 – Vaccinations
Multiple Pricing Indicator Code A : Not applicable as HCPCS priced under one methodology
Certification and additional reference information
Coverage
Coverage: C – Carrier judgment
Type of service
Berenson-Eggers Type of Service (BETOS): O1G – Immunizations/Vaccinations
Type Of Service 1: V – Pneumococcal/flu vaccine (eff 01/96), Pneumococcal/flu/hepatitis B vaccine (eff 04/95-12/95), Pneumococcal only before 04/95
Misc information
Anesthesia Base Unit Quantity: 0
Code Added Date: 20211208
Code Effective Date: 20211208
Action Code: N – No maintenance for this code